Bioconversion of daidzein to equol by Bifidobacterium breve 15700 and Bifidobacterium longum BB536

Journal of Functional Foods

Volumn 4, Issue 4, 2012, Pages 736-745

  Elghali, Salma ^a   Mustafa, Shuhaimi ^a   Amid, Mehrnoush ^a   Manap, Mohd Yaizd ABD ^a   Ismail, Amin ^a   Abas, Faridah ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Bifidobacterium spp; Daidzein; Equol; Isoflavones; Phytoestrogens

Indexed keywords

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM;

EID: 84866166785     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2012.04.013     Document Type: Article

References (46)

1. Adlercreutz H. Phytoestrogens and cancer. Lancet Oncology 2002, 3:364-373.
2. Akaza H., Miyanaga N., Takashima N., Naito S., Hirao Y., Tsukamoto T. Comparisons of percent equol producers between prostate cancer patients and controls: Case-controlled studies of isoflavones in Japanese, Korean and American residents. Japanese Journal of Clinical Oncology 2004, 34:86-89.
3. Atkinson C., Berman S., Humbert O., Lampe J. In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production. Journal of Nutrition 2004, 134(3):596-599.
4. Atkinson C., Frankenfeld C.L., Lampe J.W. Gut bacterial metabolism of the soy isoflavone daidzein: Exploring the relevance to human health. Journal of Experimental Biology and Medicine 2005, 230:155-170.
5. Bezkorovainy, A., Miller-Catchpole, R. (1989). Biochemistry and physiology of bifidobacteria. CRC.
6. Campbell J.M., Fahey G.C., Wolf B.W. Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. Journal of Nutrition 1997, 127:130-136.
7. Chen T.R., Su Q.R., Wei K.Q. Hydrolysis of isoflavone phytoestrogens in soymilk fermented by lactobacillus and bifidobacteria cocultures. Journal of Food Biochemistry 2009, 34:1-12.
8. Cummings J., Macfarlane G. Role of intestinal bacteria in nutrient metabolism. Clinical Nutrition 1997, 16:3-11.
9. Dabek M., Mc-Crae S.I., Stevens V.J., Duncan S.H., Louis P. Distribution of β -glucosidase and β-glucuronidase activity and of β-glucuronidase gene gus in human colonic bacteria. FEMS Microbiology Ecology 2008, 66:487-495.
10. De Boever P., Deplancke B., Verstraete W. Fermentation by gut microbiota cultured in a simulator of the human intestinal microbial ecosystem is improved by supplementing a soygerm powder. The Journal of Nutrition 2000, 130:2599-2606.
11. Decroos K., Vanhemmens S., Cattoir S., Boon N., Verstraete W. Isolation and characterization of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions. Archives of Microbiology 2005, 183:45-55.
12. Desjardins M.L., Roy D., Goulet J. Growth of bifidobacteria and their enzymes profiles. Journal of Dairy Science 1990, 73:299-307.
13. Duncan A., Phipps W., Kurzer M. Phytoestrogens. Best practice and research. Journal of Clinical Endocrinology and Metabolism 2003, 17:253-271.
14. Gibson G.R. Dietary modulation of the human gut microflora using prebiotics. British Journal of Nutrition 1998, 80:S209-S212.
15. Gibson G., McCartney A., Rastall R. Prebiotics and resistance to gastrointestinal infections. British Journal of Nutrition 2005, 93:31-34.
16. Hentges D.J. Does diet influence human fecal microflora composition?. Nutrition Reviews 1980, 38:329-336.
17. Hur H., Beger R., Heinze T., Lay J., Freeman J., Dore J. Isolation of an anaerobic intestinal bacterium capable of cleaving the C-ring of the isoflavonoid daidzein. Archives of Microbiology 2002, 178:8-12.
18. Kelly G., Nelson C., Waring M., Joannou G., Reeder A. Metabolites of dietary (soya) isoflavones in human urine. Clinica Chimica Acta 1993, 223:9-22.
19. Liong M., Shah N. Effects of a Lactobacillus casei synbiotic on serum lipoprotein, intestinal microflora, and organic acids in rats. Journal of Dairy Science 2006, 89:1390-1399.
20. Lund T., Munson D., Haldy M., Setchell K., Lephart E., Handa R. Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback. Biology of Reproduction 2004, 70:1188-1195.
21. Marotti I., Bonetti A., Biavati B., Catizone P., Dinelli G. Biotransformation of common bean (Phaseolus vulgaris L.) flavonoid glycosides by Bifidobacterium species from human intestinal origin. Journal of Agricultural and Food Chemistry 2007, 55:3913-3919.
22. Maruo T., Sakamoto M., Ito C., Toda T., Benno Y. Adlercreutzia equolifaciens gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella. International Journal of Systematic and Evolutionary Microbiology 2008, 58:1221-1227.
23. Mättö J., Malinen E., Suihko M.L., Alander M., Palva A., Saarela M. Genetic heterogeneity and functional properties of intestinal bifidobacteria. Journal of Applied Microbiology 2004, 97:459-470.
24. O'Sullivan G. Probiotics. British Journal of Surgery 2001, 88:161-162.
25. Parodi P.W. The role of intestinal bacteria in the causation and prevention of cancer: Modulation by diet and probiotics. Australian Journal of Dairy Technology 1999, 54:103-121.
26. Rafii F., Davis C., Park M., Heinze T.M., Beger R.D. Variations in metabolism of the soy isoflavonoid daidzein by human intestinal microfloras from different individuals. Archives of Microbiology 2003, 180:11-16.
27. Raimondi S.R.L., De Lucia M., Amaretti A., Leonardi A., Pagnoni U.M. Bioconversion of soy isoflavones daidzin and daidzein by Bifidobacterium strains. Applied Microbiology and Biotechnology 2009, 81:943-950.
28. Reinli K., Block G. Phytoestrogens content of foods a compendium of literature values. Nutrition and Cancer 1996, 26:123-148.
29. Rowland I., Faughnan M., Hoey L., Wähälä K., Williamson G., Cassidy A. Bioavailability of phytoestrogens. The British Journal of Nutrition 2003, 89:S45.
30. Rufer C.E., Glatt H., Kulling S.E. Structural elucidation of hydroxylated metabolites of the isoflavan equol by gas chromatography-mass spectrometry and high-performance liquid chromatography mass spectrometry. Drug Metabolism and Disposition 2006, 34:51-60.
31. Sathyamoorthy N., Wang T. Differential effects of dietary phytoestrogens daidzein and equol on human breast cancer MCF-7 cells. European Journal of Cancer 1997, 33:2384-2389.
32. Scardovi V., Trovatelli L.D. The fructose-6-phosphate shunt as a peculiar pattern of hexose degradation in the genus Bifidobacterium. Annual of Microbiology and Enzymology 1965, 15:19-27.
33. Setchell K., Adlercreutz H. Mammalian lignans and phytoestrogens: Recent studies on their formation, metabolism and biological role in health and disease. Role of the Gut Flora in Toxicity and Cancer 1988, 1988:315-345.
34. Setchell K., Borriello S., Hulme P., Kirk D., Axelson M. Nonsteroidal estrogens of dietary origin: Possible roles in hormone-dependent disease. American Journal of Clinical Nutrition 1984, 40:569.
35. Setchell K., Brown N., Zimmer-Nechemias L., Brashear W., Wolfe B., Kirschner A. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. American Journal of Clinical Nutrition 2002, 76:447-453.
36. Setchell K.D.R., Cassidy A. Dietary isoflavones: Biological effects and relevance to human health. Journal of Nutrition 1999, 129:758S-767S.
37. Setchell K., Lawson A., Mitchell F., Adlercreutz H., Kirk D., Axelson M. Lignans in man and in animal species. Nature 1980, 287:740-742.
38. Setchell K., Zimmer-Nechemias L., Cai J., Heubi J. Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. American Journal of Clinical Nutrition 1998, 68:1453S-1461S.
39. Shimada Y., Yasuda S., Takahashi M., Hayashi T., Miyazawa N., Sato I. Cloning and expression of a novel NADP (H)-dependent daidzein reductase, an enzyme involved in the metabolism of daidzein, from equol-producing lactococcus strain 20-92. Applied of Environmental Microbiology 2010, 76:5892-5901.
40. Tamura D., Saitoh H., Tsushida T., Shinohara K. Bifidobacterium may affect in vitro metabolism of daidzein by fecal flora from mice and a human male equol producer. Microbial Ecology in Health and Disease 2006, 18:42-46.
41. Thawornkuno C., Tanaka M., Sone T., Asano K. Biotransformation of daidzein to equol by crude enzyme from Asaccharobacter celatus AHU1763 required an anaerobic environment. Bioscience, Biotechnology and Biochemistry 2009, 73:1435-1438.
42. Tsangalis D., Ashton J., McGill A., Shah N. Enzymic transformation of isoflavone phytoestrogens in soymilk by glucosidase producing bifidobacteria. Journal of Food Science 2002, 67:3104-3113.
43. Turner N.J., Thomson B.M., Shaw I.C. Bioactive isoflavones in functional foods: The importance of gut microflora on bioavailability. Nutrition Reviews 2003, 61:204-213.
44. Wang X., Hur H.G., Lee J.H., Kim K.T., Kim S. Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium. Applied and Environmental Microbiology 2005, 71:214-219.
45. Wang X.L., Kim J.H., Kang S., Kim S., Hur G.H. Production of phytoestrogens S-equol from daidzein in mixed culture of two anaerobic bacteria. Archives of Microbiology 2007, 187:155-160.
46. Wang X.L., Shin K.H., Hur H.G., Kim S. Enhanced biosynthesis of dihydrodaidzein and dihydrogenistein by a newly isolated bovine rumen anaerobic bacterium. Journal of Biotechnology 2005, 115:261-269.